Egypt is set to establish its first multi-purpose factory for pharmaceutical raw materials in Ain Sokhna’s industrial zone, spanning an area of 96,828 square meters and involving investments of $120 million. The project is a collaboration between the Arab Company for Pharmaceutical Raw Materials (Arab API) and the General Authority for the Suez Canal Economic Zone (SCZone), represented by the Economic Zone Investment Company, according to a statement from the Egyptian Ministry of Health and Population.
The facility will manufacture active and inactive raw materials, intermediate substances, and other essential chemicals for pharmaceutical production. It aims to strengthen Egypt’s exports, enhance its competitiveness in African and global markets, and contribute to economic growth.
During the signing ceremony, Deputy Prime Minister and Minister of Health and Population Khaled Abdel Ghaffar highlighted the factory’s pivotal role in advancing the national economy and aligning with Egypt’s broader development strategy. He emphasized the government’s commitment to attracting both local and international investments in health and industry.
The Arab API will manage the construction, operation, and oversight of the facility, ensuring compliance with environmental regulations. Meanwhile, the SCZone will provide infrastructure maintenance and other support to guarantee the project’s success.